🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Inspirational

Some moving, thought-provoking talks at @NCIResearchCtr today. Much work to be done.

💗

Come join us on May 9th to learn how to leverage your strengths and navigate transitioning to practice after training!

Superstar 🌟

So lucky I began my time in the lab at @NCI_CCR_SB learning from Shirley Nah, MD

In honor of starting R2 year, ecstatic to kick off the year with presenting our research at #ESMOGI/#WCGIC2023. Spoiler 🚨: Huge need for improvement of access of care for minority patients in metastatic colorectal cancer U.S. clinical trials to ensure equal representation!

How Inclusive are Referrals to Cancer Clinical Trials? aasurg.org/blog/how-inclu… via Assoc4AcademicSurgery

This important work is also behind studies being done now to create vaccines to hopefully treat multiple types of cancer. One of the winners is not only a woman, but an individual that left her home country and immigrated to the US in hopes of a better life for her family.

Awesome work out of the Yang lab @NCIResearchCtr Matthew Sporn

First SITC conference!

Excellent background and overview of disparities in cancer clinical trials by ⁦Selwyn M. Vickers⁩ ⁦Annals of Surgical Oncology⁩ Everyone deserves equal access to healthcare, clinical trials included. link.springer.com/article/10.124…

HERE'S THE PROBLEM: Trump is a decisive communicator but LIES. Biden tells the TRUTH but not as clearly and assertively. It's misinformation vs. democracy — the entire challenge of our nation in one debate. Ugh. #Debates2024

An inspiration!

A little bit of #SITC24. On the tail end of four days in Houston. @NCI_CCR_SB #TIL for melanoma and more! Photo courtesy of the long arms of Aaron Dinerman, MD Alex Gustafson

That’s a wrap on #SITC2024! Great showing by @NCI_CCR_SB

Funding from the NIH contributed to the development of 354 out of 356 (99.4%) of the new drugs approved by the FDA between 2010 and 2019, and 🚨 100% 🚨 of FDA approved drugs btw 2010-2016. NIH funding is the backbone of American biomedical innovation. #protecttheNIH

About a month after Donald Trump took office as the 47th US president, almost all grant-review meetings remain suspended at the US National Institutes of Health (NIH), preventing the world’s largest public funder of biomedical research from spending much of its US$47 billion

In a phase 2 trial, patients with metastatic, treatment-refractory #gastrointestinal cancers responded to neoantigen-reactive tumor-infiltrating #lymphocytes, not bulk ones, showing promise for refined immune cell therapy. #ImmuneTherapy #Neoantigens nature.com/articles/s4159…

Adoptive Cell Transfer of Tumor-Infiltrating Lymphocytes for Metastatic Acral Lentiginous Melanoma. Co-authored by Alex Gustafson and Nicholas Klemen. Read full article. brnw.ch/21wTvmj